306 related articles for article (PubMed ID: 27582413)
1. Glucagon regulates hepatic lipid metabolism via cAMP and Insig-2 signaling: implication for the pathogenesis of hypertriglyceridemia and hepatic steatosis.
Wang H; Zhao M; Sud N; Christian P; Shen J; Song Y; Pashaj A; Zhang K; Carr T; Su Q
Sci Rep; 2016 Sep; 6():32246. PubMed ID: 27582413
[TBL] [Abstract][Full Text] [Related]
2. Activation of hepatic CREBH and Insig signaling in the anti-hypertriglyceridemic mechanism of R-α-lipoic acid.
Tong X; Christian P; Zhao M; Wang H; Moreau R; Su Q
J Nutr Biochem; 2015 Sep; 26(9):921-8. PubMed ID: 26007286
[TBL] [Abstract][Full Text] [Related]
3. cAMP response element binding protein H mediates fenofibrate-induced suppression of hepatic lipogenesis.
Min AK; Jeong JY; Go Y; Choi YK; Kim YD; Lee IK; Park KG
Diabetologia; 2013 Feb; 56(2):412-22. PubMed ID: 23150180
[TBL] [Abstract][Full Text] [Related]
4. Endoplasmic reticulum-tethered transcription factor cAMP responsive element-binding protein, hepatocyte specific, regulates hepatic lipogenesis, fatty acid oxidation, and lipolysis upon metabolic stress in mice.
Zhang C; Wang G; Zheng Z; Maddipati KR; Zhang X; Dyson G; Williams P; Duncan SA; Kaufman RJ; Zhang K
Hepatology; 2012 Apr; 55(4):1070-82. PubMed ID: 22095841
[TBL] [Abstract][Full Text] [Related]
5. Hepatic CREBZF couples insulin to lipogenesis by inhibiting insig activity and contributes to hepatic steatosis in diet-induced insulin-resistant mice.
Zhang F; Hu Z; Li G; Huo S; Ma F; Cui A; Xue Y; Han Y; Gong Q; Gao J; Bian H; Meng Z; Wu H; Long G; Tan Y; Zhang Y; Lin X; Gao X; Xu A; Li Y
Hepatology; 2018 Oct; 68(4):1361-1375. PubMed ID: 29637572
[TBL] [Abstract][Full Text] [Related]
6. Thyrotropin increases hepatic triglyceride content through upregulation of SREBP-1c activity.
Yan F; Wang Q; Lu M; Chen W; Song Y; Jing F; Guan Y; Wang L; Lin Y; Bo T; Zhang J; Wang T; Xin W; Yu C; Guan Q; Zhou X; Gao L; Xu C; Zhao J
J Hepatol; 2014 Dec; 61(6):1358-64. PubMed ID: 25016220
[TBL] [Abstract][Full Text] [Related]
7. Lysine Acetylation of CREBH Regulates Fasting-Induced Hepatic Lipid Metabolism.
Kim H; Mendez R; Chen X; Fang D; Zhang K
Mol Cell Biol; 2015 Dec; 35(24):4121-34. PubMed ID: 26438600
[TBL] [Abstract][Full Text] [Related]
8. Insulin enhances the biogenesis of nuclear sterol regulatory element-binding protein (SREBP)-1c by posttranscriptional down-regulation of Insig-2A and its dissociation from SREBP cleavage-activating protein (SCAP).SREBP-1c complex.
Yellaturu CR; Deng X; Park EA; Raghow R; Elam MB
J Biol Chem; 2009 Nov; 284(46):31726-34. PubMed ID: 19759400
[TBL] [Abstract][Full Text] [Related]
9. Honokiol activates the LKB1-AMPK signaling pathway and attenuates the lipid accumulation in hepatocytes.
Seo MS; Kim JH; Kim HJ; Chang KC; Park SW
Toxicol Appl Pharmacol; 2015 Apr; 284(2):113-24. PubMed ID: 25737164
[TBL] [Abstract][Full Text] [Related]
10. Retinol binding protein 4 stimulates hepatic sterol regulatory element-binding protein 1 and increases lipogenesis through the peroxisome proliferator-activated receptor-γ coactivator 1β-dependent pathway.
Xia M; Liu Y; Guo H; Wang D; Wang Y; Ling W
Hepatology; 2013 Aug; 58(2):564-75. PubMed ID: 23300015
[TBL] [Abstract][Full Text] [Related]
11. Peroxisome proliferator-activated receptor-delta induces insulin-induced gene-1 and suppresses hepatic lipogenesis in obese diabetic mice.
Qin X; Xie X; Fan Y; Tian J; Guan Y; Wang X; Zhu Y; Wang N
Hepatology; 2008 Aug; 48(2):432-41. PubMed ID: 18627005
[TBL] [Abstract][Full Text] [Related]
12. Silibinin protects β cells from glucotoxicity through regulation of the Insig-1/SREBP-1c pathway.
Chen K; Zhao L; He H; Wan X; Wang F; Mo Z
Int J Mol Med; 2014 Oct; 34(4):1073-80. PubMed ID: 25109869
[TBL] [Abstract][Full Text] [Related]
13. Phytoceuticals in Fenugreek Ameliorate VLDL Overproduction and Insulin Resistance via the Insig Signaling Pathway.
Khound R; Shen J; Song Y; Santra D; Su Q
Mol Nutr Food Res; 2018 Mar; 62(5):. PubMed ID: 29210166
[TBL] [Abstract][Full Text] [Related]
14. Nectandrin B, a lignan isolated from nutmeg, inhibits liver X receptor-α-induced hepatic lipogenesis through AMP-activated protein kinase activation.
Choi du G; Kim EK; Yang JW; Song JS; Kim YM
Pharmazie; 2015 Nov; 70(11):733-9. PubMed ID: 26790190
[TBL] [Abstract][Full Text] [Related]
15. Oleate activates SREBP-1 signaling activity in
Lounis MA; Bergeron KF; Burhans MS; Ntambi JM; Mounier C
Am J Physiol Endocrinol Metab; 2017 Dec; 313(6):E710-E720. PubMed ID: 28851735
[TBL] [Abstract][Full Text] [Related]
16. Clusterin decreases hepatic SREBP-1c expression and lipid accumulation.
Seo HY; Kim MK; Jung YA; Jang BK; Yoo EK; Park KG; Lee IK
Endocrinology; 2013 May; 154(5):1722-30. PubMed ID: 23515283
[TBL] [Abstract][Full Text] [Related]
17. Comparison of in vivo effects of insulin on SREBP-1c activation and INSIG-1/2 in rat liver and human and rat adipose tissue.
Boden G; Salehi S; Cheung P; Homko C; Song W; Loveland-Jones C; Jayarajan S
Obesity (Silver Spring); 2013 Jun; 21(6):1208-14. PubMed ID: 23913732
[TBL] [Abstract][Full Text] [Related]
18. GLP-1 Elicits an Intrinsic Gut-Liver Metabolic Signal to Ameliorate Diet-Induced VLDL Overproduction and Insulin Resistance.
Khound R; Taher J; Baker C; Adeli K; Su Q
Arterioscler Thromb Vasc Biol; 2017 Dec; 37(12):2252-2259. PubMed ID: 29074588
[TBL] [Abstract][Full Text] [Related]
19. 2-(3-Benzoylthioureido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylic acid ameliorates metabolic disorders in high-fat diet-fed mice.
Zhang J; Zhang LN; Chen DM; Fu YY; Zhang F; Yang LL; Xia CM; Jiang HW; Tang CL; Xie ZF; Yang F; Li J; Tang J; Li JY
Acta Pharmacol Sin; 2015 Apr; 36(4):483-96. PubMed ID: 25832429
[TBL] [Abstract][Full Text] [Related]
20. Regulatory cross-talk between drug metabolism and lipid homeostasis: constitutive androstane receptor and pregnane X receptor increase Insig-1 expression.
Roth A; Looser R; Kaufmann M; Blättler SM; Rencurel F; Huang W; Moore DD; Meyer UA
Mol Pharmacol; 2008 Apr; 73(4):1282-9. PubMed ID: 18187584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
